FDA.reportPublic FDA data

Ermeza 0.03 MG/ML Oral Solution

RxCUI
2626056
RxNorm name
Ermeza 0.03 MG/ML Oral Solution
Display name
Ermeza 0.03 MG/ML Oral Solution
Full name
Ermeza 0.03 MG/ML Oral Solution
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8ceeadb4-18be-46c7-9204-68b4edfbb96bErmeza 150 MCG in 5 mL Oral Solution [PSN] · levothyroxine sodium 0.03 MG/ML Oral Solution [Ermeza] [SBD] · Ermeza 0.03 MG/ML Oral Solution [SY] · Ermeza 150 MCG per 5 ML Oral Solution [SY] · Ermeza 30 MCG per ML Oral Solution [SY]56These highlights do not include all the information needed to use ERMEZA™ safely and effectively. See full prescribing information for ERMEZA™. ERMEZA™ (levothyroxine sodium) oral solution Initial U.S. Approval: 200020220415